| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Africa prepares for COVID-19 vaccines
|
Adepoju, Paul
|
|
|
|
2 |
p. e59
|
artikel
|
| 2 |
Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic data
|
Coll, Francesc
|
|
|
|
2 |
p. e151-e163
|
artikel
|
| 3 |
Antimicrobial susceptibility testing in clinical Mycobacterium tuberculosis isolates
|
Li, Jiachen
|
|
|
|
2 |
p. e68
|
artikel
|
| 4 |
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial
|
Diacon, Andreas
|
|
|
|
2 |
p. e84-e92
|
artikel
|
| 5 |
Biphasic versus monophasic manual blood culture bottles for low-resource settings: an in-vitro study
|
Ombelet, Sien
|
|
|
|
2 |
p. e124-e132
|
artikel
|
| 6 |
Cell therapy for tuberculosis and infectious diseases?
|
Dumiak, Michael
|
|
|
|
2 |
p. e58
|
artikel
|
| 7 |
Child deaths caused by Klebsiella pneumoniae in sub-Saharan Africa and south Asia: a secondary analysis of Child Health and Mortality Prevention Surveillance (CHAMPS) data
|
Verani, Jennifer R
|
|
|
|
2 |
p. e131-e141
|
artikel
|
| 8 |
Chlamydia psittaci should be a notifiable infectious disease everywhere
|
Liu, Shaoqiong
|
|
|
|
2 |
p. e62-e63
|
artikel
|
| 9 |
Correction to Lancet Microbe 2022; published online Dec 19, 2022. https://doi.org/10.1016/S2666-5247(22)00301-9
|
|
|
|
|
2 |
p. e72
|
artikel
|
| 10 |
Correction to Lancet Microbe 2021; published online Dec 13. https://doi.org/10.1016/S2666-5247(21)00241-X
|
|
|
|
|
2 |
p. e93
|
artikel
|
| 11 |
COVID-19 and measles: double trouble for Burundi
|
Bagcchi, Sanjeet
|
|
|
|
2 |
p. e65
|
artikel
|
| 12 |
COVID-19 cytokine storm syndrome: a threshold concept
|
Chen, Luke Y C
|
|
|
|
2 |
p. e49-e50
|
artikel
|
| 13 |
COVID-19 diagnostics—not at the expense of other diseases
|
Venkatesan, Priya
|
|
|
|
2 |
p. e64
|
artikel
|
| 14 |
Diagnosing COVID-19-associated pulmonary aspergillosis
|
Verweij, Paul E
|
|
|
|
2 |
p. e53-e55
|
artikel
|
| 15 |
Discrepancies in Xpert tuberculosis testing
|
Variava, Ebrahim
|
|
|
|
2 |
p. e47-e48
|
artikel
|
| 16 |
Do not blindly trust negative diagnostic test results!
|
Buchta, Christoph
|
|
|
|
2 |
p. e102-e103
|
artikel
|
| 17 |
2020 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation
|
Kinganda-Lusamaki, Eddy
|
|
|
|
2 |
p. e109-e118
|
artikel
|
| 18 |
Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens
|
Nguyen-Tran, Hai
|
|
|
|
2 |
p. e83-e85
|
artikel
|
| 19 |
Epidemiological and molecular investigations of a point-source outbreak of Dracunculus medinensis infecting humans and dogs in Chad: a cross-sectional study
|
Guagliardo, Sarah Anne J
|
|
|
|
2 |
p. e105-e112
|
artikel
|
| 20 |
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials
|
Grais, Rebecca F
|
|
|
|
2 |
p. e70-e78
|
artikel
|
| 21 |
Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis
|
Boullé, Charlotte
|
|
|
|
2 |
p. e93-e101
|
artikel
|
| 22 |
Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis
|
Hall, Michael B
|
|
|
|
2 |
p. e84-e92
|
artikel
|
| 23 |
Funding basic sciences: a solid structure is built from the ground up
|
The Lancet Microbe,
|
|
|
|
2 |
p. e48
|
artikel
|
| 24 |
Genomic epidemiology of colistin-resistant Escherichia coli in China
|
Perez, Federico
|
|
|
|
2 |
p. e51-e52
|
artikel
|
| 25 |
Global emergence of Gram-negative bacteria carrying the mobilised RND-type efflux pump gene cluster tmexCD-toprJ variants
|
Wu, Yuye
|
|
|
|
2 |
p. e105
|
artikel
|
| 26 |
Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review
|
Smeesters, Pierre R
|
|
|
|
2 |
p. e181-e193
|
artikel
|
| 27 |
Global trends in the increasing prevalence of the fosfomycin resistance gene in Staphylococcus aureus
|
Monte, Daniel F M
|
|
|
|
2 |
p. e104
|
artikel
|
| 28 |
H9N2 avian influenza viruses: challenges and the way forward
|
Zhang, Jiahao
|
|
|
|
2 |
p. e70-e71
|
artikel
|
| 29 |
Including women in deworming the world
|
The Lancet Microbe,
|
|
|
|
2 |
p. e80
|
artikel
|
| 30 |
Inferring the multiplicity of founder variants initiating HIV-1 infection: a systematic review and individual patient data meta-analysis
|
Baxter, James
|
|
|
|
2 |
p. e102-e112
|
artikel
|
| 31 |
Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study
|
Zhang, Zhen
|
|
|
|
2 |
p. e79-e87
|
artikel
|
| 32 |
Laboratory-acquired infections and pathogen escapes worldwide between 2000 and 2021: a scoping review
|
Blacksell, Stuart D
|
|
|
|
2 |
p. e194-e202
|
artikel
|
| 33 |
Lateral thinking and antimicrobial resistance
|
The Lancet Microbe,
|
|
|
|
2 |
p. e57
|
artikel
|
| 34 |
Long-acting injectable ART for HIV: a (cautious) step forward
|
Venkatesan, Priya
|
|
|
|
2 |
p. e94
|
artikel
|
| 35 |
Low rate of bacterial co-infection in patients with COVID-19
|
Adler, Hugh
|
|
|
|
2 |
p. e62
|
artikel
|
| 36 |
Modulation of multidrug-resistant clone success in Escherichia coli populations: a longitudinal, multi-country, genomic and antibiotic usage cohort study
|
Pöntinen, Anna K
|
|
|
|
2 |
p. e142-e150
|
artikel
|
| 37 |
Monitoring investments in coronavirus research and development
|
Brown, Rebecca J
|
|
|
|
2 |
p. e61
|
artikel
|
| 38 |
More than L2b in rectal lymphogranuloma venereum
|
Fermepin, Marcelo Rodríguez
|
|
|
|
2 |
p. e55
|
artikel
|
| 39 |
Multidrug-resistant Streptococcus pneumoniae in young children
|
Patil, Sandip
|
|
|
|
2 |
p. e69
|
artikel
|
| 40 |
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study
|
Rosado, Jason
|
|
|
|
2 |
p. e60-e69
|
artikel
|
| 41 |
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
|
Meyer Sauteur, Patrick M
|
|
|
|
2 |
p. e100-e101
|
artikel
|
| 42 |
Neutrophils as a pallbearer for SARS-CoV-2 disease burden
|
Twa, David DW
|
|
|
|
2 |
p. e56
|
artikel
|
| 43 |
Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply
|
Lutter, René
|
|
|
|
2 |
p. e57
|
artikel
|
| 44 |
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis
|
Nimmo, Camus
|
|
|
|
2 |
p. e164-e172
|
artikel
|
| 45 |
PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study
|
Kim, Jee Whang
|
|
|
|
2 |
p. e119-e130
|
artikel
|
| 46 |
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda
|
Ngabonziza, Jean Claude Semuto
|
|
|
|
2 |
p. e74-e83
|
artikel
|
| 47 |
Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015–17
|
Hart, John D
|
|
|
|
2 |
p. e142-e150
|
artikel
|
| 48 |
Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial
|
Piewngam, Pipat
|
|
|
|
2 |
p. e75-e83
|
artikel
|
| 49 |
Public health surveillance of infectious diseases: beyond point mutations
|
Goodman, Laura B
|
|
|
|
2 |
p. e53-e54
|
artikel
|
| 50 |
Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study
|
Duffy, Shannon C
|
|
|
|
2 |
p. e66-e73
|
artikel
|
| 51 |
Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis
|
Heysell, Scott
|
|
|
|
2 |
p. e49-e50
|
artikel
|
| 52 |
Representative oral microbiome data for the US population: the National Health and Nutrition Examination Survey
|
Vogtmann, Emily
|
|
|
|
2 |
p. e60-e61
|
artikel
|
| 53 |
Reproducibility in science: important or incremental?
|
Lee, Robyn S
|
|
|
|
2 |
p. e59-60
|
artikel
|
| 54 |
RT-PCR genotyping assays to identify SARS-CoV-2 variants in England in 2021: a design and retrospective evaluation study
|
Bray, Neil
|
|
|
|
2 |
p. e173-e180
|
artikel
|
| 55 |
Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial
|
Iwata, Hiroaki
|
|
|
|
2 |
p. e96-e104
|
artikel
|
| 56 |
SARS-CoV-2 antigen-detecting rapid tests for the delta variant
|
Bekliz, Meriem
|
|
|
|
2 |
p. e90
|
artikel
|
| 57 |
Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
|
Tonn, Torsten
|
|
|
|
2 |
p. e63
|
artikel
|
| 58 |
Survivability of highly pathogenic avian influenza virus on raw chicken meat in different environmental conditions
|
Dai, Manman
|
|
|
|
2 |
p. e92
|
artikel
|
| 59 |
Thank you to The Lancet Microbe clinical and statistical peer reviewers in 2021
|
|
|
|
|
2 |
p. e87-e89
|
artikel
|
| 60 |
Thank you to The Lancet Microbe's statistical and peer reviewers in 2022
|
The Lancet Microbe Editors,
|
|
|
|
2 |
p. e64-e66
|
artikel
|
| 61 |
The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
|
Fan, Huahao
|
|
|
|
2 |
p. e91
|
artikel
|
| 62 |
The immeasurable value of peer reviewers
|
Sekkides, Onisillos
|
|
|
|
2 |
p. e86
|
artikel
|
| 63 |
The interplay between community and hospital Enterococcus faecium clones within health-care settings: a genomic analysis
|
van Hal, Sebastiaan J
|
|
|
|
2 |
p. e133-e141
|
artikel
|
| 64 |
The Mini-Lab: accessible clinical bacteriology for low-resource settings
|
Natale, Alessandra
|
|
|
|
2 |
p. e56-e58
|
artikel
|
| 65 |
The need for better diagnostics to support diagnosis and surveillance in monkeypox endemic countries
|
Khalil, Asma
|
|
|
|
2 |
p. e67
|
artikel
|
| 66 |
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline
|
Frost, Isabel
|
|
|
|
2 |
p. e113-e125
|
artikel
|
| 67 |
The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities
|
Aggarwal, Dinesh
|
|
|
|
2 |
p. e151-e158
|
artikel
|
| 68 |
Towards a coordinated strategy for intercepting human disease emergence in Africa
|
Forbes, Kristian M
|
|
|
|
2 |
p. e51-e52
|
artikel
|
| 69 |
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
|
Vianello, Eleonora
|
|
|
|
2 |
p. e113-e123
|
artikel
|
| 70 |
Treating the symptoms of climate change
|
The Lancet Microbe,
|
|
|
|
2 |
p. e99
|
artikel
|
| 71 |
2023 UN High-Level Meeting on tuberculosis
|
Burki, Talha
|
|
|
|
2 |
p. e107
|
artikel
|
| 72 |
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
|
Nadesalingam, Angalee
|
|
|
|
2 |
p. e58-e59
|
artikel
|
| 73 |
Viral dynamics of omicron variants in older patients
|
Gao, Yuan
|
|
|
|
2 |
p. e106
|
artikel
|
| 74 |
War in Ukraine impacts immunisation
|
Holt, Ed
|
|
|
|
2 |
p. e108
|
artikel
|
| 75 |
We risk letting a new threat expose us to old enemies
|
The Lancet Microbe,
|
|
|
|
2 |
p. e44
|
artikel
|
| 76 |
WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
|
Zhu, Feng
|
|
|
|
2 |
p. e81-e82
|
artikel
|
| 77 |
WHO publish fungal priority pathogens list
|
Burki, Talha
|
|
|
|
2 |
p. e74
|
artikel
|
| 78 |
World Antimicrobial Awareness Week 2022
|
Barksby, Rebecca
|
|
|
|
2 |
p. e73
|
artikel
|
| 79 |
Yellow fever and infectious diseases in Venezuela
|
Bagcchi, Sanjeet
|
|
|
|
2 |
p. e95
|
artikel
|
| 80 |
Zoonotic tuberculosis: a complex issue of the Mycobacterium tuberculosis complex
|
Vitale, María
|
|
|
|
2 |
p. e45-e46
|
artikel
|
Tijdschrift beschrijving